Ares Allergy Holdings Plc: Notice of Extraordinary General Meeting on 27 October 2015

Regulatory News:

The shareholders of the company Ares Allergy Holdings plc (Paris:STAGR) (Euronext: STAGR) are hereby informed that they are invited to attend the Extraordinary General Meeting at Palais Brongniart, 28 Place de la Bourse, 75002 Paris - France, on 27 October 2015, at 2:00 p.m. CET.

Notice of the meeting is available on the Ares Allergy Holdings plc's website (www.aresallergy.com). It contains the agenda for this General Meeting, the draft resolution proposed by the Board of Directors and the main conditions under which shareholders may participate, vote and exercise their rights.

All the documents at the disposal of the shareholders as part of the General Meeting are available at the registered office of the Company in London (1 Curzon Street, London W1J 5HD, United Kingdom) and in Antony (6 rue Alexis de Tocqueville, 92160 Antony, France) as well as on the Company’s website (www.aresallergy.com), in the "2015 General Meeting” section.

ABOUT ARES ALLERGY HOLDINGS PLC

Headquartered in London (UK), Ares Allergy Holdings plc is a global company specialising in the diagnosis and treatment of allergies through the development and commercialization of allergy immunotherapy products and services. Ares Allergy Holdings plc is the parent company of Greer Laboratories, Inc. (whose registered office is in the U.S.) and STALLERGENES SAS (whose registered office is in France).

Trading information:
Name: Stallergenes Greer
ISIN: GB00BZ21RF93 1 - Ticker: STAGR
ICB classification: 4577
Market: Euronext Paris regulated market

Additional information is available at http://www.aresallergy.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20150921005998/en/